Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

SHA:600285 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,131	12,480	9,649	7,358	8,920	4,809
Market Cap Growth	0.14%	29.34%	31.14%	-17.51%	85.47%	-14.44%
Enterprise Value	11,331	11,552	8,482	6,324	8,108	4,064
Last Close Price	21.54	21.32	15.93	11.70	13.62	7.01
PE Ratio	15.36	17.27	16.98	15.81	24.67	14.78
Forward PE	15.02	16.50	16.45	14.45	15.43	15.43
PS Ratio	3.21	3.57	2.91	2.45	3.31	2.06
PB Ratio	3.69	4.05	3.45	2.88	3.90	2.07
P/TBV Ratio	5.00	4.35	3.73	3.14	4.37	2.32
P/FCF Ratio	13.53	16.40	12.18	9.11	11.60	12.70
P/OCF Ratio	11.94	14.25	11.86	8.81	10.55	10.68
EV/Sales Ratio	3.00	3.30	2.56	2.11	3.01	1.74
EV/EBITDA Ratio	12.86	14.52	12.76	13.65	18.11	10.57
EV/EBIT Ratio	13.98	15.96	14.40	16.25	21.54	12.85
EV/FCF Ratio	12.64	15.19	10.71	7.83	10.55	10.73
Debt / Equity Ratio	0.16	0.03	0.07	0.06	0.12	0.07
Debt / EBITDA Ratio	0.60	0.12	0.31	0.34	0.63	0.43
Debt / FCF Ratio	0.59	0.13	0.26	0.20	0.37	0.44
Asset Turnover	0.71	0.72	0.73	0.74	0.74	0.69
Inventory Turnover	1.77	1.88	1.86	1.83	1.86	1.77
Quick Ratio	0.90	1.07	1.11	1.16	1.16	1.45
Current Ratio	1.08	1.31	1.37	1.47	1.48	1.80
Return on Equity (ROE)	25.94%	24.58%	21.21%	19.21%	15.73%	14.28%
Return on Assets (ROA)	9.52%	9.24%	8.08%	5.98%	6.49%	5.83%
Return on Invested Capital (ROIC)	28.63%	41.04%	38.32%	26.85%	21.97%	16.61%
Return on Capital Employed (ROCE)	24.10%	23.00%	20.50%	14.80%	16.00%	13.20%
Earnings Yield	6.59%	5.79%	5.89%	6.32%	4.05%	6.77%
FCF Yield	7.39%	6.10%	8.21%	10.98%	8.62%	7.87%
Dividend Yield	4.10%	4.22%	5.02%	5.13%	3.67%	5.71%
Payout Ratio	64.16%	62.47%	60.60%	62.08%	61.91%	55.03%
Buyback Yield / Dilution	-1.46%	0.42%	0.30%	-0.26%	0.24%	1.22%
Total Shareholder Return	2.64%	4.64%	5.33%	4.87%	3.91%	6.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.